150 related articles for article (PubMed ID: 38379383)
1. Attention-deficit hyperactivity disorder and psychostimulant use in patients seeking dental care-Associations with common orofacial pain complaints.
Malacarne A; Jain S; Barouxis L; Walterscheid B; Finkelman M
J Oral Rehabil; 2024 Jun; 51(6):947-953. PubMed ID: 38379383
[TBL] [Abstract][Full Text] [Related]
2. The effects of psychostimulants on oral health and saliva in children with attention deficit hyperactivity disorder: A case-control study.
Ertugrul CC; Kirzioglu Z; Aktepe E; Savas HB
Niger J Clin Pract; 2018 Sep; 21(9):1213-1220. PubMed ID: 30156210
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of and Factors Associated With Long-term Concurrent Use of Stimulants and Opioids Among Adults With Attention-Deficit/Hyperactivity Disorder.
Wei YJ; Zhu Y; Liu W; Bussing R; Winterstein AG
JAMA Netw Open; 2018 Aug; 1(4):e181152. PubMed ID: 30646105
[TBL] [Abstract][Full Text] [Related]
4. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
5. Associated Factors of Attention-Deficit/Hyperactivity Disorder Diagnosis and Psychostimulant Use: A Nationwide Representative Study.
Arruda MA; Arruda R; Guidetti V; Bigal ME; Landeira-Fernandez J; Portugal AC; Anunciação L
Pediatr Neurol; 2022 Mar; 128():45-51. PubMed ID: 35066370
[TBL] [Abstract][Full Text] [Related]
6. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
[TBL] [Abstract][Full Text] [Related]
7. Meta-Analysis: Reduced Risk of Anxiety with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
Coughlin CG; Cohen SC; Mulqueen JM; Ferracioli-Oda E; Stuckelman ZD; Bloch MH
J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):611-7. PubMed ID: 26402485
[TBL] [Abstract][Full Text] [Related]
8. Psychostimulants: Influence on Body Mass Index and Height in a Pediatric Population with Attention-Deficit/Hyperactivity Disorder?
Lentferink YE; van de Garde EMW; Knibbe CAJ; van der Vorst MMJ
J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):530-536. PubMed ID: 29768018
[TBL] [Abstract][Full Text] [Related]
9. Psychostimulant treatment and the developing cortex in attention deficit hyperactivity disorder.
Shaw P; Sharp WS; Morrison M; Eckstrand K; Greenstein DK; Clasen LS; Evans AC; Rapoport JL
Am J Psychiatry; 2009 Jan; 166(1):58-63. PubMed ID: 18794206
[TBL] [Abstract][Full Text] [Related]
10. Response/remission with guanfacine extended-release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.
Cutler AJ; Brams M; Bukstein O; Mattingly G; McBurnett K; White C; Rubin J
J Am Acad Child Adolesc Psychiatry; 2014 Oct; 53(10):1092-101. PubMed ID: 25245353
[TBL] [Abstract][Full Text] [Related]
11. Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.
Spencer TJ; Greenbaum M; Ginsberg LD; Murphy WR
J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):501-10. PubMed ID: 19877974
[TBL] [Abstract][Full Text] [Related]
12. Guanfacine extended release as adjunctive therapy to psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.
Childress AC
Adv Ther; 2012 May; 29(5):385-400. PubMed ID: 22610723
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of bruxism in children receiving treatment for attention deficit hyperactivity disorder: a pilot study.
Malki GA; Zawawi KH; Melis M; Hughes CV
J Clin Pediatr Dent; 2004; 29(1):63-7. PubMed ID: 15554406
[TBL] [Abstract][Full Text] [Related]
14. Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: a population-based, birth cohort study.
Katusic SK; Barbaresi WJ; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ
J Child Adolesc Psychopharmacol; 2005 Oct; 15(5):764-76. PubMed ID: 16262593
[TBL] [Abstract][Full Text] [Related]
15. Attention-deficit/hyperactivity disorder and obesity in US males and females, age 8-15 years: National Health and Nutrition Examination Survey 2001-2004.
Byrd HC; Curtin C; Anderson SE
Pediatr Obes; 2013 Dec; 8(6):445-53. PubMed ID: 23325553
[TBL] [Abstract][Full Text] [Related]
16. Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use.
Arria AM; Caldeira KM; O'Grady KE; Vincent KB; Johnson EP; Wish ED
Pharmacotherapy; 2008 Feb; 28(2):156-69. PubMed ID: 18225963
[TBL] [Abstract][Full Text] [Related]
17. Attention-deficit hyperactivity disorder.
Calis KA; Grothe DR; Elia J
Clin Pharm; 1990 Aug; 9(8):632-42. PubMed ID: 1974836
[TBL] [Abstract][Full Text] [Related]
18. The pathophysiology, medical management and dental implications of adult attention-deficit/hyperactivity disorder.
Friedlander AH; Yagiela JA; Mahler ME; Rubin R
J Am Dent Assoc; 2007 Apr; 138(4):475-82; quiz 535, 537. PubMed ID: 17403737
[TBL] [Abstract][Full Text] [Related]
19. Persistence and Adherence to Psychostimulants, and Psychological Well-Being Up to 3 Years After Specialized Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Naturalistic Follow-Up Study.
Bijlenga D; Kulcu S; van Gellecum T; Eryigit Z; Kooij JJS
J Clin Psychopharmacol; 2017 Dec; 37(6):689-696. PubMed ID: 29049077
[TBL] [Abstract][Full Text] [Related]
20. A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder.
Wilens TE; Bukstein O; Brams M; Cutler AJ; Childress A; Rugino T; Lyne A; Grannis K; Youcha S
J Am Acad Child Adolesc Psychiatry; 2012 Jan; 51(1):74-85.e2. PubMed ID: 22176941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
